Quote:
UPDATE 4-GlaxoSmithKline settles healthcare fraud case for $3 bln, Reuters, David Ingram, Tue Jul 3, 2012 12:29am IST.
http://in.reuters.com/article/2012/07/0 ... J620120702“ . . . GSK targeted the antidepressant Paxil to patients under age 18 when it was approved for adults only, and it pushed the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction, . . ”
“ . . . The company went to extreme lengths to promote the drugs, such as distributing a misleading medical journal article and providing doctors with meals and spa treatments that amounted to illegal kickbacks, prosecutors said. . . ”
“ . . . In a third instance, GSK failed to give the U.S. Food and Drug Administration safety data about its diabetes drug Avandia, . . ”
“ . . . The company will not be able to compensate its salesmen based on sales goals for territories. . . ”
I myself sometimes experience and struggle with bouts of depression. I have not yet tried antidepressants, but they are kind of my Ace in the hole. My plan is 5 antidepressants, 5 months, because it typically takes a month to tell if one is working or not. In a reputable sense, it is trial and error. And sometimes it's also important to step down from an antidepressant in stages (like 2/3's dose, half-dose, one-third dose), even if the damn thing doesn't seem to be working (apparently your body still gets somewhat used to it none the less).
http://articles.latimes.com/2009/aug/03 ... ing-drugs3
And yes, it is important that the company be reasonably open and honest.
02 Jul 2012, 5:01 pm
